We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+13.55%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$257M
AUM Growth
+$20.3M
Cap. Flow
-$3.38M
Cap. Flow %
-1.32%
Top 10 Hldgs %
33.42%
Holding
167
New
24
Increased
41
Reduced
51
Closed
33

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$2.37M
2
ULTA icon
Ulta Beauty
ULTA
+$2.18M
3
COP icon
ConocoPhillips
COP
+$2.04M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.97M
5
EMR icon
Emerson Electric
EMR
+$1.81M

Top Sells

Rank Stock Value
1
COF icon
Capital One
COF
+$4.77M
2
UBER icon
Uber
UBER
+$3.19M
3
PANW icon
Palo Alto Networks
PANW
+$2.27M
4
CRWD icon
CrowdStrike
CRWD
+$2.23M
5
DHI icon
D.R. Horton
DHI
+$2.13M

Sector Composition

Rank Sector Weight
1 Industrials 24.01%
2 Healthcare 17.6%
3 Financials 14.71%
4 Technology 12.6%
5 Communication Services 8.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CFR icon
126
Cullen/Frost Bankers
CFR
$10.3B
$278K 0.11%
1,800
– –
AMD icon
127
Advanced Micro Devices
AMD
$776B
$276K 0.11%
+475
New +$195K
FAF icon
128
First American
FAF
$7.66B
$271K 0.11%
3,950
– –
TRV icon
129
Travelers Companies
TRV
$78.1B
$260K 0.1%
787
– –
BNY
130
Bank of New York Mellon
BNY
$106B
$246K 0.1%
1,700
– –
WMS icon
131
Advanced Drainage Systems
WMS
$10.6B
$228K 0.09%
+1,450
New +$207K
SLB icon
132
SLB Ltd
SLB
$73.6B
$223K 0.09%
4,792
– –
MET icon
133
MetLife
MET
$61.9B
$209K 0.08%
+2,475
New +$200K
COMP icon
134
Compass
COMP
$8.51B
$133K 0.05%
10,797
– –
APO icon
135
Apollo Global Management
APO
$72.4B
– –
-6,500
Closed -$724K
AVAV icon
136
AeroVironment
AVAV
$7.56B
– –
-5,050
Closed -$924K
BA icon
137
Boeing
BA
$171B
– –
-3,058
Closed -$609K
BWXT icon
138
BWX Technologies
BWXT
$15.5B
– –
-2,300
Closed -$470K
CAT icon
139
Caterpillar
CAT
$375B
– –
-1,250
Closed -$886K
CME icon
140
CME Group
CME
$96.3B
– –
-735
Closed -$217K
COF icon
141
Capital One
COF
$128B
– –
-26,125
Closed -$4.77M
CRWD icon
142
CrowdStrike
CRWD
$194B
– –
-22,840
Closed -$2.23M
DAL icon
143
Delta Air Lines
DAL
$57.5B
– –
-29,317
Closed -$1.95M
DHI icon
144
D.R. Horton
DHI
$40B
– –
-15,550
Closed -$2.13M
FLS icon
145
Flowserve
FLS
$9.71B
– –
-11,200
Closed -$823K
FSLR icon
146
First Solar
FSLR
$22.7B
– –
-7,852
Closed -$1.55M
GIS icon
147
General Mills
GIS
$19.1B
– –
-7,200
Closed -$268K
GNRC icon
148
Generac Holdings
GNRC
$11.6B
– –
-2,300
Closed -$449K
HON icon
149
Honeywell
HON
$77B
– –
-1,368
Closed -$309K
HOOD icon
150
Robinhood
HOOD
$77.8B
– –
-9,850
Closed -$683K
3 4 5
6
7

Similar funds

GCCM
Gate City Capital Management Chicago, Illinois $257M AUM 37.12% 1-Year Est. Return
EBWM
Eagle Bluffs Wealth Management Columbia, Missouri $257M AUM 30.19% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return
ACM
ADW Capital Management Miami Beach, Florida $257M AUM 11.22% 1-Year Est. Return
CCA
Cruiser Capital Advisors Stamford, Connecticut $257M AUM 65.27% 1-Year Est. Return
PHAM
Palisades Hudson Asset Management Fort Lauderdale, Florida $257M AUM 21.62% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
TC
Towle & Co Denver, Colorado $257M AUM 73.13% 1-Year Est. Return

New England Research & Management's Q2 2026 Portfolio in Review

As of Q2 2026, New England Research & Management held 167 positions worth $257M, up 8.6% from $237M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

New England Research & Management's Q2 2026 filing shows 24 new, 41 increased, 51 reduced and 33 closed positions. Its largest new stake was Ulta Beauty: 4,303 shares worth $1.94M. The largest sale was Capital One, an estimated $4.77M.

By sector, the portfolio is most concentrated in Industrials at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • New England Research & Management's largest Q2 2026 buy was Ulta Beauty: 4,303 shares worth $1.94M.
  • New England Research & Management added most to AstraZeneca in Q2 2026, an estimated $2.37M increase.
  • New England Research & Management's biggest Q2 2026 reduction was Idexx Laboratories, cutting an estimated $1.82M.
  • New England Research & Management fully exited Capital One in Q2 2026, selling an estimated $4.77M.
  • New England Research & Management's ten largest holdings make up 33% of its $257M portfolio in Q2 2026.
  • New England Research & Management opened 24 new positions and closed 33 in Q2 2026.
  • New England Research & Management's portfolio value rose 8.6% quarter-over-quarter to $257M.

Based on New England Research & Management's 13F filing for Q2 2026, filed 9 Jul 2026.